Most of the new capacity will be dedicated to manufacturing active pharmaceutical ingredients, including for Wegovy and Ozempic, used to treat diabetes and obesity.
The U.S. has been experiencing its worst year for drug shortages in a decade, with Sanofi and AstraZeneca's new RSV shot for infants as the latest high-profile example.
A supply shortage means a drug that can prevent RSV in infants won't have a major immediate impact, children's hospitals said, and they are preparing for a surge in admissions this respiratory disease season.
A Medicare proposal to help alleviate major shortages of cancer drugs and other essential medicines could disadvantage facilities serving vulnerable populations and instigate new supply issues.
Rite Aid has settled a critical dispute with drug supplier McKesson Corp. to ensure that customers' prescriptions will continue to be filled during Rite Aid's bankruptcy.